Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01264-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Cong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, 250021, Shandong,…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Guanosine, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundation, Technology Development Project of Jinan City.
Abstract (Originalsprache)
N7-methylguanosine (m7G) occurs by adding a methyl group to the N7 atom of the RNA guanine. Emerging evidence suggests that m7G modification has emerged as a crucial regulator of tumorigenesis, progression, invasion, and metastasis in multiple cancers. Nevertheless, the utility of m7G modification in diffuse large B-cell lymphoma (DLBCL) remains undefined, notably the interaction with the tumor microenvironment (TME). Here, we aimed to identify the expression profile of m7G regulators in DLBCL, construct a novel risk model, and explore their connection with TME. We initially investigated the difference and correlation in m7G regulators' expression in normal and tumor groups, classified patients by consistent clustering analysis, investigated the functional and prognostic significance of the resulting subtypes, and identified prognosis-associated genes by one-way Cox and least absolute shrinkage and selection operator (LASSO) regression calculations, and constructed a risk model. Further analysis showed that correlation among immune cell infiltration with m7G risk score and determined that it impacts the prognosis of DLBCL patients. Our research demonstrated the relevance of m7G regulators to DLBCL prognosis, providing theoretical support for precise prognostic stratification and immunotherapeutic assessment in DLBCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
- Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
- Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, 250021, Shandong, China. dingmei1105@sina.com.
- Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, 250021, Shandong, China. xiangxiangzhou@sdu.edu.cn.
- Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, No.324, Jingwu Road, Jinan, 250021, Shandong, China. xiangxiangzhou@sdu.edu.cn.
Förderung
- Shandong Provincial Natural Science Foundation
- Technology Development Project of Jinan City
Zitieren
APA
Wang, C., Kong, R., Zhong, G., Li, P., Wang, N., Feng, G., Ding, M., & Zhou, X. (2025). Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01264-w
Vancouver
Wang C, Kong R, Zhong G, Li P, Wang N, Feng G, et al. Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01264-w
BibTeX
@article{Wang2025,
author = {Wang, Cong and Kong, Ran and Zhong, Guangcai and Li, Peipei and Wang, Na and Feng, Ganyu and Ding, Mei and Zhou, Xiangxiang},
title = {Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01264-w}
}
EUVIMED